High Times Presents: The U.S. Cannabis Cup

sativex

High Hypocrisy: US Gov’s Ploy to Capitalize on Marijuana

Cannabis-based medicine may be on its way to winning the approval of the United States government, but this will likely have no impact of marijuana’s illegal status. 

FDA: Yes to Marijuana Spray, Will Not Reclassify

In a time when natural marijuana is considered by the American government to be a gateway to the downtrodden of civil society, it seems odd, but not surprising, that the United States would be champing at the bit to approve cannabis-based medicine. 

Big Pharma Blocking Feds From Legalizing Marijuana?

While most of America is still struggling to legalize marijuana for medicinal purposes, a handful of large pharmaceutical companies are already generating a substantial amount of revenue from prescription drugs based on cannabis medicine. 

Cannabis Spray Only for the Rich?

For the past several months, HIGH TIMES has been providing extensive coverage on GW Pharmaceuticals’ popular cannabis-based drug called Sativex, which in addition to being recognized for years in some countries as a treatment option for multiple scler...

France Approves Cannabis-Based Medicine

Cannabis-based medicine will soon be available in France, as the country’s health officials recently approved commercial sales of the drug for the first time in history. A report from the Associated Press indicates that Britain’s GW Pharmaceuticals has been gr...

Pages

Notice

Important notice for Seattle US Cannabis Cup attendees.
A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

This company is not affiliated with HIGH TIMES Magazine in any way. If you have purchased a travel package from High Times Travel LLC please contact HIGH TIMES immediately by emailing us at travelcomplaint@hightimes.com